Controversial FDA official Dr. Vinay Prasad departs agency
'Dr. Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family,' a spokesperson for the US Department of Health and Human Services told CNN on Tuesday.
Prasad, a hematologist oncologist, was named head of the FDA's Center for Biologics Evaluation and Research in early May, giving him purview over vaccines and biologic medicines. He was subsequently also given the role of FDA chief medical and scientific officer. Like a number of Trump administration health appointees, Prasad had been a harsh critic of the government's response and vaccine policies during the Covid-19 pandemic.
Prasad's departure came amid fresh pressure from the White House for him to resign, according to a person familiar with the matter who was granted anonymity to describe the internal dynamics, and followed days of criticism from Laura Loomer, a right-wing activist with extraordinary access to President Donald Trump.
Loomer had taken shots at him on her website and on social media, attacking him publicly for days as a 'progressive leftist saboteur' who was 'undermining President Trump's FDA.'
Loomer focused on Prasad's previous social media posts and podcast episodes, where she said he aligned himself politically with liberal politicians and expressed 'disdain' for Trump. Her posts were followed by others from figures including former US Sen. Rick Santorum, who called Prasad 'the man destroying @POTUS legacy for helping patients,' and a Wall Street Journal opinion piece headlined, 'Vinay Prasad Is a Bernie Sanders Acolyte in MAHA Drag.'
Prasad didn't respond to requests for comment. A White House spokesperson referred a request for comment to HHS.
Prasad had been defended by FDA Commissioner Dr. Marty Makary just days ago; in an interview with Politico, Makary said Prasad is an 'impeccable scientist … one of the greatest scientific minds of our generation.'
'We thank him for his service and the many important reforms he was able to achieve in his time at FDA,' the spokesperson for HHS said.
Prasad assumed his role at the FDA after years of being a vocal critic of some of the agency's drug approvals. In particular, he had railed against a decision to approve Sarepta's drug for Duchenne muscular dystrophy, Elevidys, arguing that there was little evidence it helped stall or reverse symptoms of the rare, fatal genetic disorder.
This month, the FDA requested that Sarepta halt shipments of the drug after a reported death in a young patient in Brazil. Just one day before Prasad's departure, the agency made a surprising reversal and allowed Sarepta to resume shipments for certain patients.
Prasad also drew criticism from former officials and vaccine experts after internal memos from May revealed that he overrode FDA scientists on recommendations for two new versions of Covid-19 vaccines. The then-CDER director rebuked recommendations for broad use of the shots; the FDA eventually approved the vaccines for use in older and immunocompromised people but did not advise them for younger Americans who don't have underlying conditions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
25 minutes ago
- New York Post
Trump repeats claim Kimmel, Fallon are ‘next' after Stephen Colbert cancellation
President Donald Trump doubled down on Wednesday that late-night hosts Jimmy Fallon and Jimmy Kimmel would be 'next' to be canceled during a press conference. During the presser, Real America's Voice reporter Brian Glenn asked about reports that radio host Howard Stern may part ways with Sirius XM after his contract expires this fall. Advertisement With that in mind, Glenn asked if the 'hate Trump' entertainment model was losing popularity with Americans. Trump cited CBS' recent cancellation of 'The Late Show with Stephen Colbert' as an example and added that he believes Fallon and Kimmel are next. 'Well, it hasn't worked,' Trump said. 'And it hasn't worked, really, for a long time, and I would say pretty much from the beginning. Colbert has no talent. I mean, I could take anybody here. I could go outside in the beautiful streets and pick a couple of people that do just as well or better. They'd get higher ratings than he did. He's got no talent.' He continued, 'Fallon has no talent. Kimmel has no talent. They're next. They're going to be going. I hear they're going to be going. I don't know, but I would imagine because they'd get—you know, Colbert has better ratings than Kimmel or Fallon.' Advertisement 4 President Trump suggested Jimmy Fallon and Jimmy Kimmel's late-night shows are 'next' to be canceled. AP 4 CBS announced 'The Late Show with Stephen Colbert' will end in May 2026. AP Trump made a similar declaration on Truth Social after Colbert's show was canceled last month. 'The word is, and it's a strong word at that, Jimmy Kimmel is NEXT to go in the untalented Late Night Sweepstakes and, shortly thereafter, Fallon will be gone,' Trump wrote. Advertisement He continued, 'These are people with absolutely NO TALENT, who were paid Millions of Dollars for, in all cases, destroying what used to be GREAT Television. It's really good to see them go, and I hope I played a major part in it!' 4 'Jimmy Kimmel is NEXT to go in the untalented Late Night Sweepstakes,' President Trump wrote on Truth Social. AP 4 President Trump predicted that 'The Tonight Show with Jimmy Fallon' would be dropped by NBC. Rosalind O'Connor/NBC via Getty Images Advertisement Although some liberal commentators claimed CBS canceled Colbert's show for political reasons to appease Trump, Paramount—CBS' parent company—insisted it was 'purely a financial decision.' Regarding Stern, Trump remarked how he used to 'have fun' when he appeared on his show. He went on to say that Stern went downhill after endorsing Hillary Clinton for president in 2016. 'He lost his audience. People said give me a break. He went down when he endorsed Hillary Clinton,' Trump said.
The Hill
25 minutes ago
- The Hill
The Latest: Trump's tariffs go into effect
The U.S. began officially levying higher taxes on imports from dozens of countries Thursday, four months after President Donald Trump first announced plans to impose tariffs on most of the world while seeking new trade agreements across the board. The White House said that starting just after midnight goods from more than 60 countries and the European Union would face tariff rates of 10% or higher. Products from the European Union, Japan and South Korea will be taxed at 15%, while imports from Taiwan, Vietnam and Bangladesh will be taxed at 20%. Trump also expects places such as the EU, Japan and South Korea to invest hundreds of billions of dollars in the U.S. The Trump White House is confident that the onset of his broad tariffs will provide clarity about the path of the world's largest economy. Now that companies understand the direction the U.S. is headed, the administration believes they can ramp up new investments and jump-start hiring in ways that can rebalance the U.S. economy as a manufacturing power. But so far, economic data has shown a U.S. economy that began flagging after Trump's initial rollout of tariffs in April. Here's the latest: Tariffs to affect more than half of Indian exports to the U.S. A top body of Indian exporters said Thursday the latest U.S. tariffs will impact nearly 55% of the country's outbound shipments to America and force exporters to lose their long-standing clients. 'Absorbing this sudden cost escalation is simply not viable. Margins are already thin,' S.C. Ralhan, president of the Federation of Indian Export Organisations, said in a statement. The tariffs effectively impose a cost burden, placing Indian exporters at a competitive disadvantage with countries that have lesser import taxes, he added. In 2024, the U.S. ran a $45.8 billion trade deficit in goods with India, meaning America imported more from India than it exported, according to the U.S. Census Bureau. American consumers and businesses buy pharmaceutical drugs, precious stones, and textiles and apparel from India, among other goods. Modi vows to defend farmers' interests Prime Minister Narendra Modi on Thursday said India will never compromise the interests of farmers. 'For us, the interests of farmers are a top priority. I know I will have to personally pay a heavy price for it, but I am ready,' Modi said at a conference in what was seen as a message to the U.S. administration, which has been seeking greater access to India's agriculture and dairy sectors. India and the U.S. have had five rounds of negotiations on a bilateral trade agreement, but haven't been able to clinch one so far. On Wednesday, Trump signed an executive order to place an additional 25% tariff on India for its purchases of Russian oil. The order would go into effect in 21 days and bring the combined tariffs imposed on India to 50%. Sony profits are up Japanese entertainment and electronics company Sony said Thursday its profit surged 23% in the last quarter from the year before, as damage from U.S. President Donald Trump's tariffs was less than it had expected. Sony raised its forecast for its profit in the full fiscal year until March 2026 to 970 billion yen ($6.6 billion), from an earlier forecast of 930 billion yen ($6.3 billion). The revised projection is still lower than what it earned in the previous fiscal year at 1 trillion yen. Sony now estimates the impact of the additional U.S. tariffs on its operating income at 70 billion yen ($476 million), much better than the initial estimate of 100 billion yen ($680 million).
San Francisco Chronicle
25 minutes ago
- San Francisco Chronicle
The Latest: Trump's tariffs go into effect
The U.S. began officially levying higher taxes on imports from dozens of countries Thursday, four months after President Donald Trump first announced plans to impose tariffs on most of the world while seeking new trade agreements across the board. The White House said that starting just after midnight goods from more than 60 countries and the European Union would face tariff rates of 10% or higher. Products from the European Union, Japan and South Korea will be taxed at 15%, while imports from Taiwan, Vietnam and Bangladesh will be taxed at 20%. Trump also expects places such as the EU, Japan and South Korea to invest hundreds of billions of dollars in the U.S. The Trump White House is confident that the onset of his broad tariffs will provide clarity about the path of the world's largest economy. Now that companies understand the direction the U.S. is headed, the administration believes they can ramp up new investments and jump-start hiring in ways that can rebalance the U.S. economy as a manufacturing power. But so far, economic data has shown a U.S. economy that began flagging after Trump's initial rollout of tariffs in April. A top body of Indian exporters said Thursday the latest U.S. tariffs will impact nearly 55% of the country's outbound shipments to America and force exporters to lose their long-standing clients. 'Absorbing this sudden cost escalation is simply not viable. Margins are already thin,' S.C. Ralhan, president of the Federation of Indian Export Organisations, said in a statement. The tariffs effectively impose a cost burden, placing Indian exporters at a competitive disadvantage with countries that have lesser import taxes, he added. In 2024, the U.S. ran a $45.8 billion trade deficit in goods with India, meaning America imported more from India than it exported, according to the U.S. Census Bureau. American consumers and businesses buy pharmaceutical drugs, precious stones, and textiles and apparel from India, among other goods. Prime Minister Narendra Modi on Thursday said India will never compromise the interests of farmers. 'For us, the interests of farmers are a top priority. I know I will have to personally pay a heavy price for it, but I am ready,' Modi said at a conference in what was seen as a message to the U.S. administration, which has been seeking greater access to India's agriculture and dairy sectors. India and the U.S. have had five rounds of negotiations on a bilateral trade agreement, but haven't been able to clinch one so far. On Wednesday, Trump signed an executive order to place an additional 25% tariff on India for its purchases of Russian oil. The order would go into effect in 21 days and bring the combined tariffs imposed on India to 50%. Sony profits are up Japanese entertainment and electronics company Sony said Thursday its profit surged 23% in the last quarter from the year before, as damage from U.S. President Donald Trump's tariffs was less than it had expected. Sony raised its forecast for its profit in the full fiscal year until March 2026 to 970 billion yen ($6.6 billion), from an earlier forecast of 930 billion yen ($6.3 billion). The revised projection is still lower than what it earned in the previous fiscal year at 1 trillion yen. Sony now estimates the impact of the additional U.S. tariffs on its operating income at 70 billion yen ($476 million), much better than the initial estimate of 100 billion yen ($680 million).
